Literature DB >> 33853339

COVID-19 reinfections.

K Fabiánová, J Kynčl, I Vlčková, H Jiřincová, J Košťálová, M Liptáková, H Orlíková, H Šebestová, R Limberková, B Macková, M Malý.   

Abstract

Reports of SARS-CoV-2 reinfections are on the rise. This study focused on reinfections in patients with confirmed COVID-19 in the Czech Republic. Between 1 March 2020 and 9 November 2020, 362 084 cases with the onset of symptoms before 31 October 2020 were reported. Overall, 28 cases of symptomatic SARS-CoV-2 reinfections were identified, 11 in males and 17 in females, age range 25-80 years, median age 46 years. The interval between the first and second episodes of the disease ranged from 101 to 231 days, and the median interval was 201.5 days. During both symptomatic episodes, all patients have been tested by RT-PCR. Altogether 26 patients (92.9%) have been tested negative after recovery from the first episode of COVID-19. Symptomatic reinfections occurred in nearly 0.2% of all patients at risk. Most patients with reinfection had mild symptoms in both episodes, and only three episodes were moderate to severe. Thus, reinfections may have been underdiagnosed. In summary, COVID-19 reinfections are possible and not exceptional.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; coronavirus; reinfection

Year:  2021        PMID: 33853339

Source DB:  PubMed          Journal:  Epidemiol Mikrobiol Imunol        ISSN: 1210-7913            Impact factor:   0.444


  5 in total

1.  Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain.

Authors:  Cristina Rodríguez-Grande; Luis Alcalá; Agustín Estévez; Pedro J Sola-Campoy; Sergio Buenestado-Serrano; Carolina Martínez-Laperche; Víctor Manuel de la Cueva; Roberto Alonso; Cristina Andrés-Zayas; Javier Adán-Jiménez; Carmen Losada; Carla Rico-Luna; Iñaki Comas; Fernando González-Candelas; Pilar Catalán; Patricia Muñoz; Laura Pérez-Lago; Darío García de Viedma
Journal:  Emerg Infect Dis       Date:  2021-11-29       Impact factor: 6.883

Review 2.  SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity.

Authors:  Stefan Pilz; Verena Theiler-Schwetz; Christian Trummer; Robert Krause; John P A Ioannidis
Journal:  Environ Res       Date:  2022-02-08       Impact factor: 8.431

3.  Genomic evidence of SARS-CoV-2 reinfection in the Republic of Korea.

Authors:  Ae Kyung Park; Jee Eun Rhee; Il-Hwan Kim; Heui Man Kim; Hyeokjin Lee; Jeong-Ah Kim; Chae Young Lee; Nam-Joo Lee; SangHee Woo; Jaehee Lee; Jin Sun No; Gi-Eun Rhie; Seong Jin Wang; Sang-Eun Lee; Young Joon Park; Gemma Park; Jung Yeon Kim; Jin Gwack; Cheon-Kwon Yoo; Eun-Jin Kim
Journal:  J Med Virol       Date:  2021-12-09       Impact factor: 20.693

4.  Multiple Routes of Antibody-Dependent Enhancement of SARS-CoV-2 Infection.

Authors:  Kosuke Okuya; Takanari Hattori; Takeshi Saito; Yoshihiro Takadate; Michihito Sasaki; Wakako Furuyama; Andrea Marzi; Yoichi Ohiro; Satoshi Konno; Takeshi Hattori; Ayato Takada
Journal:  Microbiol Spectr       Date:  2022-03-23

5.  SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria.

Authors:  Georgi K Marinov; Mladen Mladenov; Antoni Rangachev; Ivailo Alexiev
Journal:  PLoS One       Date:  2022-09-09       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.